ABOGEN Trademark

Trademark Overview


On Tuesday, January 18, 2022, a trademark application was filed for ABOGEN with the United States Patent and Trademark Office. The USPTO has given the ABOGEN trademark a serial number of 79337360. The federal status of this trademark filing is OPPOSITION PENDING as of Monday, March 27, 2023. This trademark is owned by Suzhou Abogen Biosciences Co., Ltd.. The ABOGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of viral diseases; human vaccine preparations; oral vaccine preparations; vaccines; immunostimulants; antivirals; pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; bacteriological preparations for medical purposes; vaccines against pneumococcal infections; vaccine preparations

Cancer research for medical purposes; scientific investigations for medical purposes; product quality testing; medical research; development of pharmaceutical preparations and pharmaceuticals; medical research services; pharmaceutical research services; medicines research services; research and development services relating to medicines; computer programming in the medical field
abogen

General Information


Serial Number79337360
Word MarkABOGEN
Filing DateTuesday, January 18, 2022
Status774 - OPPOSITION PENDING
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "ABOGEN".
Goods and ServicesPharmaceuticals for the treatment of viral diseases; human vaccine preparations; oral vaccine preparations; vaccines; immunostimulants; antivirals; pharmaceutical preparations for the treatment or prevention of cancer, immune diseases, genetic disorders and infectious diseases; bacteriological preparations for medical purposes; vaccines against pneumococcal infections; vaccine preparations
Goods and ServicesCancer research for medical purposes; scientific investigations for medical purposes; product quality testing; medical research; development of pharmaceutical preparations and pharmaceuticals; medical research services; pharmaceutical research services; medicines research services; research and development services relating to medicines; computer programming in the medical field

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuzhou Abogen Biosciences Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameSuzhou Abogen Biosciences Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Monday, March 27, 2023OPPOSITION INSTITUTED NO. 999999
Wednesday, March 22, 2023OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, March 22, 2023OPPOSITION NOTICE (IB REFUSAL) CREATED
Thursday, December 15, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2022REFUSAL PROCESSED BY IB
Friday, August 26, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 26, 2022REFUSAL PROCESSED BY MPU
Wednesday, August 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 16, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 10, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB